{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:06:42Z","timestamp":1771049202184,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007374","name":"UFMG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.antiviral.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T08:12:56Z","timestamp":1517991176000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In vitro susceptibility to ST-246 and Cidofovir corroborates the phylogenetic separation of Brazilian Vaccinia virus into two clades"],"prefix":"10.1016","volume":"152","author":[{"given":"Mariana A.","family":"Pires","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia F.S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo B.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe L.","family":"de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galileu B.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erna G.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno E.F.","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.02.005_bib1","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1128\/JVI.00605-06","article-title":"Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice","volume":"80","author":"Andrei","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.005_bib2","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/v2122803","article-title":"Cidofovir activity against poxvirus infections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.02.005_bib3","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3201\/eid1812.120145","article-title":"Group 2 vaccinia virus, Brazil","volume":"18","author":"Assis","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.005_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00705-010-0857-z","article-title":"Assessing the variability of Brazilian Vaccinia virus isolates from a horse exanthematic lesion: coinfection with distinct viruses","volume":"156","author":"Campos","year":"2011","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2018.02.005_bib6","article-title":"Basal activation of type I interferons (Alpha2 and beta) and 2\u20325\u2032OAS genes: insights into differential expression profiles of interferon system components in systemic sclerosis","volume":"2011","author":"de Oliveira","year":"2011","journal-title":"Internet J. Rheumatol."},{"key":"10.1016\/j.antiviral.2018.02.005_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid0902.020244","article-title":"Ara\u00e7atuba virus: a vaccinialike virus associated with infection in humans and cattle","volume":"9","author":"de Souza Trindade","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","article-title":"Human monkeypox: an emerging zoonosis","volume":"4","author":"Di Giulio","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.micinf.2007.11.005","article-title":"Brazilian Vaccinia virus strains are genetically divergent and differ from the Lister vaccine strain","volume":"10","author":"Drumond","year":"2008","journal-title":"Microb. Infect."},{"key":"10.1016\/j.antiviral.2018.02.005_bib10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/jac\/dku545","article-title":"ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping","volume":"70","author":"Duraffour","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib11","doi-asserted-by":"crossref","first-page":"e55808","DOI":"10.1371\/journal.pone.0055808","article-title":"Emergence of cowpox: study of the virulence of clinical strains and evaluation of antivirals","volume":"8","author":"Duraffour","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.02.005_bib12","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1177\/135965350701200802","article-title":"Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures","volume":"12","author":"Duraffour","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.02.005_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/135965350801300817","article-title":"Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently","volume":"13","author":"Duraffour","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.02.005_bib14","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"110","key":"10.1016\/j.antiviral.2018.02.005_bib15","article-title":"Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkey poxvirus","volume":"7","author":"Farlow","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2018.02.005_bib16","doi-asserted-by":"crossref","first-page":"e3043","DOI":"10.1371\/journal.pone.0003043","article-title":"Virulence in murine model shows the existence of two distinct populations of Brazilian Vaccinia virus strains","volume":"3","author":"Ferreira","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.02.005_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cimid.2016.03.003","article-title":"The detection of Vaccinia virus confirms the high circulation of Orthopoxvirus in buffaloes living in geographical isolation, Maraj\u00f3 Island, Brazilian Amazon","volume":"46","author":"Franco-Luiz","year":"2016","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virusres.2007.04.014","article-title":"In vivo imaging of cidofovir treatment of cowpox virus infection","volume":"128","author":"Goff","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.02.005_bib19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1073\/pnas.0912134107","article-title":"Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice","volume":"107","author":"Grosenbach","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2018.02.005_bib20","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"Huggins","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijantimicag.2008.07.015","article-title":"In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC","volume":"33","author":"Jesus","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2018.02.005_bib23","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification","volume":"53","author":"Jordan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib24","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.47.7.2193-2198.2003","article-title":"Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication","volume":"47","author":"Keith","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/AAC.48.5.1869-1871.2004","article-title":"Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro","volume":"48","author":"Keith","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib26","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.00380-06","article-title":"Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype","volume":"50","author":"Kornbluth","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2011.08.018","article-title":"Zoonotic Brazilian Vaccinia virus: from field to therapy","volume":"92","author":"Kroon","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.005_bib28","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/molbev\/msx149","article-title":"SMS: smart model selection in PhyML","volume":"34","author":"Lefort","year":"2017","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.antiviral.2018.02.005_bib29","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3201\/eid1112.050773","article-title":"Passatempo virus, a vaccinia virus strain, Brazil","volume":"11","author":"Leite","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib30","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/AAC.00977-13","article-title":"Efficacy of tecovirimat (ST-246) in nonhuman Primates infected with Variola virus (smallpox)","volume":"57","author":"Mucker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2012.11.010","article-title":"Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246\u00ae","volume":"97","author":"Santos-Fernandes","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.005_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000070618","article-title":"Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice","volume":"49","author":"Smee","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.antiviral.2018.02.005_bib33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/AAC.01044-08","article-title":"In vitro efficacy of ST246 against smallpox and monkeypox","volume":"53","author":"Smith","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.02.005_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3201\/eid1307.061404","article-title":"Brazilian vaccinia viruses and their origins","volume":"13","author":"Trindade","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib35","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1086\/595856","article-title":"Zoonotic vaccinia virus: clinical and immunological characteristics in a naturally infected patient","volume":"48","author":"Trindade","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4269\/ajtmh.2006.75.486","article-title":"Short report: isolation of two vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: implications on the emergence of zoonotic orthopox viruses","volume":"75","author":"Trindade","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2018.02.005_bib37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccinee","volume":"46","author":"Vora","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/QCO.0b013e3282f44c74","article-title":"Cowpox virus infection: an emerging health threat","volume":"21","author":"Vorou","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.005_bib39","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:34:20Z","timestamp":1660437260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217306368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"alternative-id":["S0166354217306368"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro susceptibility to ST-246 and Cidofovir corroborates the phylogenetic separation of Brazilian Vaccinia virus into two clades","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}